Skip to main content

We narrowed to 41,485 results for: KAN;

Showing: 961 - 980 of 41485 results
  1. pAAV-EF1a>WAChR_1m-G-Soma-E-HA-P2A-mScarlet; WPRE3-BGH polyA; KanR

    Plasmid
    #247728
    Purpose
    Constitutive bicistronic expression via P2A cleavage: {WAChR-1m}-{Kir2.1 Golgi tag}-{Kv2.1 soma tag}-{Kir2.1 ER tag}-{HA tag} + {mScarlet}
    Depositor
    Insert
    WAChR_1m-G-Soma-E-HA-P2A-mScarlet
    Use
    AAV
    Tags
    mScarlet
    Expression
    Mammalian
    Mutation
    S122L/F240A
    Promoter
    EF1a
    Available Since
    Dec. 19, 2025
    Availability
    Academic Institutions and Nonprofits only
  2. pNQL001-WAPL-AID[71-114]-eGFP-FRT-Neo/Kan-FRT targeting construct

    Plasmid
    #175549
    Purpose
    Targeting vector to introduce an AID-eGFP cassette at the mouse WAPL locus using Neomycin/Kanamycin selection. Auxin-inducible degron system.
    Depositor
    Insert
    WAPL (Wapl Mouse)
    Use
    Mouse Targeting
    Tags
    AID[71-114]-eGFP
    Expression
    Mammalian
    Mutation
    none
    Available Since
    Nov. 5, 2021
    Availability
    Academic Institutions and Nonprofits only
  3. The Expanded CRISPEY Kit

    Plasmid Kit
    #1000000257
    Purpose
    Use the Expanded CRISPEY Kit for CRISPR-based gene editing of the Saccharomyces cerevisiae genome.
    Depositor
    Application
    Genome Editing
    Vector Type
    Yeast Expression
    Editing Type
    CRISPR
    Available Since
    May 6, 2025
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (AAV8)

    Viral Prep
    #228902-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (#228902). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine plasmid DNA. CAG-driven, Cre dependent expression of a peripherally restricted DREADD. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Chicken Beta Actin
    Tags
    mCitrine
    Available Since
    Oct. 8, 2025
    Availability
    Academic Institutions and Nonprofits only
  5. AAV_pMBP-EGFP-caax (AAV8)

    Viral Prep
    #190155-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV_pMBP-EGFP-caax (#190155). In addition to the viral particles, you will also receive purified AAV_pMBP-EGFP-caax plasmid DNA. MBP-driven EGFP expression in oligodendrocytes. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    MBP
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV.GFA104.PI.eGFP.WPRE.bGH (AAV5)

    Viral Prep
    #100896-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFA104.PI.eGFP.WPRE.bGH (#100896). In addition to the viral particles, you will also receive purified pAAV.GFA104.PI.eGFP.WPRE.bGH plasmid DNA. GFA104-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFA104 (GFAP promoter)
    Tags
    EGFP
    Available Since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only
  7. AAV_pMBP-EGFP-caax (AAV1)

    Viral Prep
    #190155-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV_pMBP-EGFP-caax (#190155). In addition to the viral particles, you will also receive purified AAV_pMBP-EGFP-caax plasmid DNA. MBP-driven EGFP expression in oligodendrocytes. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    MBP
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only
Showing: 961 - 980 of 41485 results